Product Images Kyxata
View Photos of Packaging, Labels & Appearance
- Image - 0674943f 7498 497e b788 a9f12e62383d 112 1
- Image - 1960f327 faf2 49b2 b6ad df9340c0ebc3 01
- KYXATA (CARBOplatin) Injection, 20 mg/2 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 02
- KYXATA (CARBOplatin) Injection, 20 mg/2 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 03
- KYXATA (CARBOplatin) Injection, 80 mg/8 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 04
- KYXATA (CARBOplatin) Injection, 80 mg/8 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 05
- KYXATA (CARBOplatin) Injection, 500 mg/50 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 06
- KYXATA (CARBOplatin) Injectionn, 500 mg/50 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 07
- Image - 1960f327 faf2 49b2 b6ad df9340c0ebc3 178 2
Product Label Images
The following 9 images provide visual information about the product associated with Kyxata NDC 83831-140 by Avyxa Pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 0674943f 7498 497e b788 a9f12e62383d 112 1
Image - 1960f327 faf2 49b2 b6ad df9340c0ebc3 01
KYXATA (CARBOplatin) Injection, 20 mg/2 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 02
KYXATA (CARBOplatin) Injection, 20 mg/2 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 03
This text excerpt contains information about a medication called KYXATA, specifically a 2 mL multiple-dose vial containing 20 mg of Carboplatin, USP, and Water for Injection. It provides details regarding dosage, storage instructions, expiration date, and the manufacturer's information. The medication is intended for intravenous use and is labeled as a hazardous drug. It is important to follow the prescribing information and store the vial appropriately to maintain its efficacy.*
KYXATA (CARBOplatin) Injection, 80 mg/8 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 04
KYXATA (CARBOplatin) Injection, 80 mg/8 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 05
This is a product label for a carboplatin injection solution. The medication is used intravenously and comes in an 80 mg/8 mL (10 mg/mL) concentration. It is a hazardous drug and should be stored between 20°C and 25°C (68°F to 77°F), with excursions permitted from 15°C to 30°C (59°F to 86°F). The solution should be protected from light and partially used vials stored in their original carton. The vials do not contain any preservatives. It is recommended to discard the solution after 28 days of first use. The product is manufactured for Aupra Pharma, LLC, in New Jersey, USA.*
KYXATA (CARBOplatin) Injection, 500 mg/50 mL (10 mg/mL) -Vial Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 06
KYXATA (CARBOplatin) Injectionn, 500 mg/50 mL (10 mg/mL) -Carton Label - 1960f327 faf2 49b2 b6ad df9340c0ebc3 07
This is a product description for KYXATA™ (CARBOplatin) Injection, containing 500 mg of Garboplatin per 50 mL vial for Intravenous Use. The medication is classified as a Hazardous Drug and is supplied as a Sterile Multiple-dose Vial. The vial does not contain any preservatives. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Once opened, the partially used vial should be stored in the original carton at the same temperature and discarded after 28 days. The product is manufactured for Avxa Pharma, LLC in the USA and made in Switzerland.*
Image - 1960f327 faf2 49b2 b6ad df9340c0ebc3 178 2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
